Catalyst Wire Dossier Catalyst Wire Dossier

[111In]-FPI-2107

Indium-111 labeled FPI-2107 · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [111In]-FPI-2107, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC [Phase 1]

See pricing